News & Updates
Filter by Specialty:
Men with PsA derive more benefit from MTX+ETN therapy than women
Combination therapy with methotrexate (MTX) plus etanercept (ETN) results in more improved outcomes in men than in women with psoriatic arthritis (PsA) for minimal disease activity (MDA) and Psoriatic Arthritis Disease Activity Score (PASDAS), a study has shown.
Men with PsA derive more benefit from MTX+ETN therapy than women
09 Aug 2022
Ivabradine SR improves heart function in patients with HFrEF
Once-daily treatment with sustained-release (SR) ivabradine hemisulfate, alongside optimum standard therapy, results in better heart function in patients with chronic heart failure with reduced ejection fraction (HFrEF), reports a study.
Ivabradine SR improves heart function in patients with HFrEF
08 Aug 2022
BP-lowering drug helps prevent Parkinson’s disease
Treatment with angiotensin receptor blockers (ARBs) appears to reduce the risk of Parkinson’s disease (PD) in patients newly diagnosed with hypertension, reports a recent study.
BP-lowering drug helps prevent Parkinson’s disease
08 Aug 2022
Tenofovir in mothers plus HBIG in infants best prevent vertical HBV transmission
For mothers with hepatitis B virus (HBV) infection who are positive for both hepatitis B surface and envelope antigens, administering a combination of hepatitis B vaccine and immunoglobulin (HBIG) in their infants plus tenofovir disoproxil fumarate (TDF) in the mothers themselves appears to be the best approach for preventing vertical disease transmission, according to a study.
